Royalty Pharma Plc

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB00BMVP7Y09
USD
39.15
-0.38 (-0.96%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
2,263.58
2,354.55
2,237.22
2,289.46
2,122.35
1,814.25
1,794.89
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,263.58
2,354.55
2,237.22
2,289.46
2,122.35
1,814.25
1,794.89
Raw Material Cost
0.00
0.00
5.67
23.00
0.00
0.00
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
225.51
187.19
187.96
166.14
156.54
275.46
290.15
Selling and Distribution Expenses
236.67
249.75
227.30
182.83
181.72
103.44
61.91
Other Expenses
-22.35
-13.52
-1.09
3.39
-13.02
-19.24
10.25
Total Expenditure (Excl Depreciation)
238.67
301.75
410.08
405.91
208.00
186.47
454.51
Operating Profit (PBDIT) excl Other Income
2024.9
2052.8
1827.1000000000001
1883.6000000000001
1914.3000000000002
1627.8
1340.3999999999999
Other Income
75.43
79.44
54.61
28.37
35.95
-15.98
427.38
Operating Profit (PBDIT)
1,367.87
1,571.59
983.17
1,482.08
1,654.41
2,631.12
1,825.09
Interest
225.51
187.19
187.96
166.14
156.54
275.46
290.15
Exceptional Items
188.46
315.69
-559.47
-51.74
227.14
129.68
16.18
Gross Profit (PBDT)
0.00
0.00
2,231.55
2,266.47
0.00
0.00
0.00
Depreciation
0.00
0.00
5.67
23.00
23.06
23.92
33.27
Profit Before Tax
1,330.81
1,700.09
230.06
1,241.20
1,701.95
2,461.42
1,517.86
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
858.98
1,134.83
42.83
619.73
975.04
2,348.53
1,377.73
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
858.98
1,134.83
42.83
619.73
975.04
2,348.53
1,377.73
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
471.83
565.25
187.23
621.47
726.91
112.88
140.13
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,330.81
1,700.09
230.06
1,241.20
1,701.95
2,461.42
1,517.86
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
6,946.58
6,526.50
5,628.15
5,776.59
4,818.78
6,105.56
4,488.21
Earnings per share (EPS)
1.91
2.53
0.1
1.49
2.6
6.42
2.27
Diluted Earnings per share
1.91
2.53
0.1
1.49
2.6
6.42
2.27
Operating Profit Margin (Excl OI)
57.1%
63.37%
41.25%
62.49%
75.17%
144.59%
76.02%
Gross Profit Margin
58.79%
72.2%
10.54%
55.22%
81.28%
136.99%
86.42%
PAT Margin
37.95%
48.2%
1.91%
27.07%
45.94%
129.45%
76.76%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -3.86% vs 5.25% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -21.72% vs 638.85% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -13.39% vs 60.69% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 20.46% vs -0.43% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Royalty Pharma Plc With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
2,263.58
14,709.70
-12,446.12
-84.61%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,263.58
14,709.70
-12,446.12
-84.61%
Raw Material Cost
0.00
8,485.20
-8,485.20
-100.00%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
225.51
554.70
-329.19
-59.35%
Selling and Distribution Expenses
236.67
3,560.80
-3,324.13
-93.35%
Other Expenses
-22.35
24.82
-47.17
-190.05%
Total Expenditure (Excl Depreciation)
238.67
12,848.90
-12,610.23
-98.14%
Operating Profit (PBDIT) excl Other Income
2,024.90
1,860.80
164.10
8.82%
Other Income
75.43
-337.60
413.03
122.34%
Operating Profit (PBDIT)
1,367.87
4,231.70
-2,863.83
-67.68%
Interest
225.51
554.70
-329.19
-59.35%
Exceptional Items
188.46
-1,591.70
1,780.16
111.84%
Gross Profit (PBDT)
0.00
6,224.50
-6,224.50
-100.00%
Depreciation
0.00
2,708.50
-2,708.50
-100.00%
Profit Before Tax
1,330.81
-623.20
1,954.01
313.54%
Tax
0.00
11.00
-11.00
-100.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
858.98
-634.20
1,493.18
235.44%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
858.98
-634.20
1,493.18
235.44%
Share in Profit of Associates
0
0
0.00
Minority Interest
471.83
0.00
471.83
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,330.81
-634.20
1,965.01
309.84%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
6,946.58
18,635.50
-11,688.92
-62.72%
Earnings per share (EPS)
1.91
-0.53
2.44
460.38%
Diluted Earnings per share
1.91
-0.53
2.44
460.38%
Operating Profit Margin (Excl OI)
57.10%
12.65%
0.00
44.45%
Gross Profit Margin
58.79%
14.18%
0.00
44.61%
PAT Margin
37.95%
-4.31%
0.00
42.26%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 226.36 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -3.86% vs 5.25% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 133.08 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -21.72% vs 638.85% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 129.24 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -13.39% vs 60.69% in Dec 2023

Annual - Interest
Interest 22.55 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 20.46% vs -0.43% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 57.10%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023